TMED3 promotes prostate cancer via FOXO1a and FOXO3a phosphorylation.
Wei X, Liang J, Huang H, Yang D, Wang X, Wang X, Chen C, Li K, Pang T, Hu B, Wu F.
Wei X, et al. Among authors: pang t.
Oncol Res. 2024 Dec 20;33(1):161-169. doi: 10.32604/or.2024.048054. eCollection 2025.
Oncol Res. 2024.
PMID: 39735675
Free PMC article.